Does Bladder Instillation Reduce Time to Discharge After Sling Surgery

Sponsor
Cedars-Sinai Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT02277288
Collaborator
(none)
250
1
2
168
1.5

Study Details

Study Description

Brief Summary

The purpose of this randomized control trial study is to determine if intraoperative bladder instillation of fluid decreases the time to discharge after having an outpatient mid-urethral sling procedure, and to measure the cost savings of this decrease in hospital stay. Charges will be broken down between recovery room charges and discharge area, as recovery room charges are significantly higher. The investigators suspect that a shorter time in the recovery room will translate into fewer charges.

Condition or Disease Intervention/Treatment Phase
  • Other: Filled bladder arm
N/A

Detailed Description

Urinary stress incontinence affects 4-35% of women. Due to the large economic impact and prevalence of the disease, urinary incontinence is a significant public health issue. With rising healthcare costs it has become increasingly important to manage patient care in the most cost-efficient manner. Considering the increasing number of women undergoing mid-urethral sling procedures, it is imperative that perioperative care is streamlined in order to minimize cost. The Cedars-Sinai Center for Continence and Women's Pelvic Health instituted a new practice pattern that enables patients to complete a voiding trial sooner after surgery compared to previous practice patterns thus allowing patients to be discharged earlier and ultimately decreasing cost. The purpose of this study is to compare the previous voiding trial practice (emptying the bladder at the end of surgery) versus the newly instituted practice (filling with bladder with 250cc) and perform a cost benefit analysis to determine if there is a significant decrease in recovery and discharge time. Both of these practices fall under the standard-of-care. However, of the several standard-of-care procedures, none have been tested for superiority. To date there are no randomized control trials that address this issue in female mid-urethral sling surgery.

Boccola et al showed in a study of 60 men who had undergone transurethral resection of the prostate (TURP) that by instilling the bladder with 300-500cc of warm saline the time to void was significantly decreased compared to standard indwelling catheter removal. It was also shown that the bladder instillation group had a significantly shorter time to discharge. The study suggested that given the significant decrease in time in recovery, this would be an ideal practice for many other outpatient procedures. Willson, et al, in another randomized trial of 75 men who underwent TURP, found that bladder infusion allowed early decision-making for discharge on the second postoperative day. Finally, McAchran and Goldman found that when patients were managed using a fast-track regimen in the outpatient setting after mid-urethral sling procedures the median time from the recovery area to discharge was less than 3 hours.

For our study, if a significant decrease in the time to discharge with the newly instituted practice pattern is demonstrated, then this practice can be adopted by other institutions and become the new standard of care to help decrease both cost and patient time in the hospital.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
250 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Does Intraoperative Bladder Instillation Decrease Outpatient Recovery Time After Mid-Urethral Sling
Study Start Date :
Dec 1, 2011
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Emptied bladder arm

No instillation of fluid into bladder.

Experimental: Filled bladder arm

Instilled bladder with fluid.

Other: Filled bladder arm
Bladder to be instilled with 200 cc fluid during cystoscopy and no catheter for all mid-urethral sling procedures.

Outcome Measures

Primary Outcome Measures

  1. Time between surgery and discharge home [2 Days]

    Will analyze if the time to discharge is shorter in those patients who have had bladder instillation versus those with an indwelling catheter postoperatively.

Secondary Outcome Measures

  1. Hospital charges [1 Month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Female

  2. Age 18 years or older

  3. History of stress urinary incontinence

  4. Scheduled for outpatient mid-urethral sling procedure, any approach

Exclusion Criteria:
  1. Age less than 18 years

  2. Pregnancy

  3. Inability to give informed consent

  4. History of urinary retention

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cedars-Sinai Medical Center Beverly Hills California United States 90211

Sponsors and Collaborators

  • Cedars-Sinai Medical Center

Investigators

  • Principal Investigator: Jennifer Anger, MD, MPH, Cedars-Sinai Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jennifer T. Anger, Principal Investigator, Cedars-Sinai Medical Center
ClinicalTrials.gov Identifier:
NCT02277288
Other Study ID Numbers:
  • Pro00026292
First Posted:
Oct 29, 2014
Last Update Posted:
Jul 18, 2018
Last Verified:
Jul 1, 2018
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2018